Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,871
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway

Shan JinShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChina
,
Qibin LiaoShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChina
,
Jian ChenShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChina
,
Linxia ZhangShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChina
,
Qian HeShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChina
,
Huanzhang ZhuState Key Laboratory of Genetic Engineering and Key Laboratory of Medical Molecular Virology of Ministry of Education/Health, School of Life SciencesFudan UniversityShanghaiChina
,
Xiaoyan ZhangShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChinaCorrespondence[email protected]
&
Jianqing XuShanghai Public Health Clinical Center and Institutes of Biomedical Sciences, Key Laboratory of Medical Molecular Virology, Shanghai Medical CollegeFudan UniversityShanghaiChina;State Key Laboratory for Infectious Disease Prevention and ControlChina Centers for Disease Control and PreventionBeijingChinaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-0896-9273
ORCID Icon show all
Pages 1-11 | Received 15 Apr 2018, Accepted 23 Jun 2018, Published online: 08 Aug 2018

References

  • RuelasDSGreeneWCAn integrated overview of HIV-1 latencyCell2013155 519 52910.1016/j.cell.2013.09.0444361081
  • SilicianoRFGreeneWCHIV latencyCold Spring Harb. Perspect. Med.20111a00709610.1101/cshperspect.a0070963234450
  • ChunTWIn vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latencyNat. Med.199511284129010.1038/nm1295-1284
  • Shan, L. et al. Transcriptional reprogramming during effector-to-memory transition renders CD4(+) T cells permissive for latent HIV-1 infection. Immunity47, 766–775.e3 (2017)..
  • PaceMJDirectly infected resting CD4+ T cells can produce HIV Gag without spreading infection in a model of HIV latencyPLoS Pathog.20128e100281810.1371/journal.ppat.10028183406090
  • ChavezLCalvaneseVVerdinEHIV latency is established directly and early in both resting and activated primary CD4 T cellsPLoS Pathog.201511e100495510.1371/journal.ppat.10049554466167
  • WiresESMethamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and induces human immunodeficiency virus (HIV) transcription in human microglial cellsJ. Neurovirol.20121840041010.1007/s13365-012-0103-43469781
  • MarbanCRecruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencingEMBO J.20072641242310.1038/sj.emboj.76015161783449
  • KandathilAJSugawaraSBalagopalAAre T cells the only HIV-1 reservoir?Retrovirology20161310.1186/s12977-016-0323-45175311
  • Lenasi, T., Contreras, X. & Peterlin, B. M. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell. Host Microbe4, 123–133 (2008).
  • GallasteguiEMillan-ZambranoGTermeJMChavezSJordanAChromatin reassembly factors are involved in transcriptional interference promoting HIV latencyJ. Virol.2011853187320210.1128/JVI.01920-103067836
  • NabelGBaltimoreDAAn inducible transcription factor activates expression of human immunodeficiency virus in T cellsNature198732671171310.1038/326711a0
  • GerritsenMECREB-binding protein/p300 are transcriptional coactivators of p65Proc. Natl Acad. Sci. USA1997942927293210.1073/pnas.94.7.2927
  • ChanJKBhattacharyyaDLassenKGRuelasDGreeneWCCalcium/calcineurin synergizes with prostratin to promote NF-kappaB dependent activation of latent HIVPLoS. ONE.20138e7774910.1371/journal.pone.00777493813743
  • PerkinsNDA cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activationEMBO J.1993123551355841363110.1002/j.1460-2075.1993.tb06029.x
  • YangXChenYGabuzdaDERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF- BJ. Biol. Chem.1999274279812798810.1074/jbc.274.39.27981
  • TyagiMKarnJCBF-1 promotes transcriptional silencing during the establishment of HIV-1 latencyEMBO J.2007264985499510.1038/sj.emboj.76019282140115
  • HendersonLJNarasipuraSDAdarichevVKashanchiFAl-HarthiLIdentification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, beta-catenin, and SMAR1 to repress HIV transcriptionJ. Virol.2012869495950310.1128/JVI.00486-123416155
  • Sherrill-MixSHIV latency and integration site placement in five cell-based modelsRetrovirology20131010.1186/1742-4690-10-903765678
  • Lewinski, M. K. et al. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol.79, 6610–6619 (2005).
  • ShanLInfluence of host gene transcription level and orientation on HIV-1 latency in a primary-cell modelJ. Virol.2011855384539310.1128/JVI.02536-103094997
  • ColEThe histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, TatJ. Biol. Chem.2001276281792818410.1074/jbc.M101385200
  • KulpaDAThe immunological synapse: the gateway to the HIV reservoirImmunol. Rev.201325430532510.1111/imr.120803707302
  • NinovNBoriusMStainierDYDifferent levels of Notch signaling regulate quiescence, renewal and differentiation in pancreatic endocrine progenitorsDevelopment20121391557156710.1242/dev.0760003317964
  • MazzoneMDose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cellsProc. Natl Acad. Sci. USA20101075012501710.1073/pnas.1000896107
  • PowellJDPollizziKNHeikampEBHortonMRRegulation of immune responses by mTORAnnu. Rev. Immunol.201230396810.1146/annurev-immunol-020711-075024
  • PalmerCSPalchaudhuriRAlbargyHAbdel-MohsenMCroweSMExploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammagingF1000Res.2018712510.12688/f1000research.11881.15791007
  • PalmerCSMetabolically active CD4+T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infectionFEBS Lett.20175913319333210.1002/1873-3468.128435658250
  • Besnard, E. et al. The mTOR complex controls HIV latency. Cell. Host Microbe.20, 785–797 (2016).
  • ArchinNMAdministration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapyNature201248748248510.1038/nature112863704185
  • ElliottJHActivation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyPLoS Pathog.201410e100447310.1371/journal.ppat.10044734231123
  • BullenCKLairdGMDurandCMSilicianoJDSilicianoRFNew ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivoNat. Med.20142042542910.1038/nm.34893981911
  • XingSDisulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activationJ. Virol.2011856060606410.1128/JVI.02033-103126325
  • ArchinNMSungJMGarridoCSoriano-SarabiaNMargolisDMEradicating HIV-1 infection: seeking to clear a persistent pathogenNat. Rev. Microbiol.20141275076410.1038/nrmicro33524383747
  • RasmussenTATolstrupMSogaardOSReversal of latency as part of a cure for HIV-1Trends Microbiol.201624909710.1016/j.tim.2015.11.003
  • SanjanaNEShalemOZhangFImproved vectors and genome-wide libraries for CRISPR screeningNat. Methods20141178378410.1038/nmeth.30474486245
  • Li, C. et al. Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells. J. Virol. 91 (2017).
  • YangXQuercetin synergistically reactivates human immunodeficiency virus type 1 latency by activating nuclear factorkappaBMol. Med. Rep.20181725012508
  • Heaton, B. E. et al. A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor. Cell Rep.20, 1503–1512 (2017).
  • du CheneISuv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latencyEMBO J.20072642443510.1038/sj.emboj.76015171783455
  • FolksTMJustementJKinterADinarelloCAFauciASCytokine-induced expression of HIV-1 in a chronically infected promonocyte cell lineScience198723880080210.1126/science.3313729
  • MoreiraJMScheipersPSorensenPThe histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responsesBMC Cancer2003310.1186/1471-2407-3-30280656
  • BanerjeeCBET bromodomain inhibition as a novel strategy for reactivation of HIV-1J. Leukoc. Biol.2012921147115410.1189/jlb.03121653501896
  • InokiKLiYXuTGuanKLRheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signalingGenes Dev.2003171829183410.1101/gad.1110003196227
  • Myers, K. A. & Scheffer, I. E. DEPDC5 as a potential therapeutic target for epilepsy. Expert. Opin. Ther. Targets.21, 591–600 (2017).
  • MargolisDMGarciaJVHazudaDJHaynesBFLatency reversal and viral clearance to cure HIV-1Science2016353aaf651710.1126/science.aaf65175021637
  • MartinARRapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicityJ. Clin. Invest.201712765165610.1172/JCI895525272184
  • PalmerCSEmerging role and characterization of immunometabolism: relevance to HIV pathogenesis, serious non-AIDS events, and a cureJ. Immunol.20161964437444410.4049/jimmunol.16001206051513
  • Oswald-Richter, K., Grill, S. M., Leelawong, M. & Unutmaz, D. HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. Eur. J. Immunol.34, 1705–1714 (2004).
  • HerediaATargeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized miceProc. Natl Acad. Sci. USA20151129412941710.1073/pnas.1511144112
  • Roy, J., Paquette, J. S., Fortin, J. F. & Tremblay, M. J. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. Antimicrob. Agents Chemother.46, 3447–3455 (2002).
  • StockPGReduction of HIV persistence following transplantation in HIV-infected kidney transplant recipientsAm. J. Transplant.2014141136114110.1111/ajt.126994012326
  • ShimobayashiMHallMNMaking new contacts: the mTOR network in metabolism and signalling crosstalkNat. Rev. Mol. Cell Biol.20141515516210.1038/nrm3757
  • JewellJLRussellRCGuanKLAmino acid signalling upstream of mTORNat. Rev. Mol. Cell Biol.20131413313910.1038/nrm35223988467
  • Bar-PeledLA Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1Science20133401100110610.1126/science.12320443728654
  • Ghosh, J. & Kapur, R. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia. Exp. Hematol.50, 13–21 (2017).
  • Mbonye, U. & Karn, J. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure. Virology454-455, 328–339 (2014).
  • PearsonREpigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latencyJ. Virol.200882122911230310.1128/JVI.01383-082593349
  • Van LintCEmilianiSOttMVerdinETranscriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylationEMBO J.1996151112112045000910.1002/j.1460-2075.1996.tb00449.x
  • BattistiniASgarbantiMHIV-1 latency: an update of molecular mechanisms and therapeutic strategiesViruses201461715175810.3390/v60417154014718
  • Ott, M., Geyer, M. & Zhou, Q. The control of HIV transcription: keeping RNA polymerase II on track. Cell. Host Microbe.10, 426–435 (2011).
  • Van Lint C., Bouchat S. & Marcello A. M. HIV-1 transcription and latency: an update. 10, 67 (2013).
  • HuangJCellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytesNat. Med.2007131241124710.1038/nm1639
  • TanidaIAutophagy basicsMicrobiol. Immunol.20115511110.1111/j.1348-0421.2010.00271.x
  • SagnierSAutophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytesJ. Virol.20158961562510.1128/JVI.02174-14
  • BorelSHIV-1 viral infectivity factor interacts with microtubule-associated protein light chain 3 and inhibits autophagyAIDS20152927528610.1097/QAD.0000000000000554
  • KrawczykCMToll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activationBlood20101154742474910.1182/blood-2009-10-2495402890190
  • MichalekRDCutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsetsJ. Immunol.20111863299330310.4049/jimmunol.10036133198034
  • LiuCMaXLiuBChenCZhangHHIV-1 functional cure: will the dream come true?Bmc. Med.20151310.1186/s12916-015-0517-y4654816

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.